Santa Cruz Biotechnology features a diverse variety of HYI Antibodies for research applications. Monoclonal HYI Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HYI, or Hydroxyisobutyric acid, plays a crucial role in metabolic processes and cellular signaling pathways. Understanding the function of HYI is essential for elucidating its involvement in various physiological and pathological conditions, including metabolic disorders and cancer. HYI research has revealed significant insights into cellular metabolism and its regulation. Investigating HYI's role in different biological processes can lead to better understanding of disease mechanisms. Recent studies have highlighted the importance of HYI in metabolic homeostasis and cellular function. Ongoing research continues to uncover new aspects of HYI's biological significance. Santa Cruz Biotechnology monoclonal HYI Antibodies support researchers worldwide in advancing scientific understanding of metabolic processes and disease mechanisms.